A phase II study of cyclophosphamide as a 24-hr infusion in advanced non-small cell lung cancer
- 1 April 1986
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (4) , 435-437
- https://doi.org/10.1016/0277-5379(86)90109-4
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancerRespiratory Medicine, 1984
- Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the futureCancer Treatment Reviews, 1983
- Therapeutic effects of single-push or fractionated injections of cyclophosphamide or ifosfamide combined with mesnaCancer Treatment Reviews, 1983
- Intermittent high-dose cyclophosphamide with and without prednisolone. A study of the relationships between toxicity, response and survival in metastatic lung cancerCancer, 1982
- Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinomaCancer, 1982
- Portable infusion pumps in ambulatory cancer chemotherapyCancer, 1982
- Methotrexate compared with placebo in lung cancerCancer, 1977